« Back to main page


Sort list by presenter     ·    by title     ·    by ID number     ·    search by keyword

Click abstract title for more information
The poster Click abstract title to view poster icon indicates a Virtual Poster can be viewed online


Displaying all abstracts in category:
Lymphoma

A Dosimetric Study of Mantle versus Involved-Field Radiotherapy for Hodgkin's Lymphoma: Implications for Second Cancer Risk and Cardiac Toxicity (2323)
Koh, Eng-Siew Click abstract title to view poster
A Prospective Study to Evaluate the Need for an Immobilization Device for Treating Modified Mantle Fields in Lymphoma Patients (2326)
Billingsley, Susan
Clinical Significance of Cyclooxygenase-2 in NK/T-Cell Lymphoma, Nasal Type (2327)
Shim, Su Jung
Extranodal Natural killer/T-cell Lymphoma of Nasal Type: The Toronto Experience (2329)
Tsang, Richard Click abstract title to view poster
Highly Effective Local Control and Palliation of Mantle Cell Lymphoma (MCL) with Involved-Field Radiation Therapy (IFRT) (2321)
Rosenbluth, Benjamin
Impact of Full Dose of Rituximab on Pharmacokinetics and Dosimetry of Zevalin for Patients with Non-Hodgkin's Lymphoma (2330)
Shen, S
Is Intensity-Modulated Radiotherapy Better than Conventional Radiation Treatment and 3D Conformal Radiotherapy for Mediastinal Masses in Patients with Hodgkin's Disease? Is there a Role for Beam Orientation Optimization and Dose Constraints Assigned to Virtual Volumes? (2325)
Ghalibafian, Mithra Click abstract title to view poster
Low Dose Total Body Irradiation Prior to Allograft for Heamtologic Malignancies: a Retrospective Review from the Acute Leukemia Working Party of the European Blood and Marrow Transplantation (2319)
Belkacemi, Yazid
Pre-Stem Cell Transplant Pulmonary Function Tests (PFTs) Predict Risk of Mortality in the Absence of Pulmonary Lung Shielding with Fractionated Total Body Irradiation (TBI) (2332)
Mansueti, John
Predictors of Response and Differential Mechanisms of Action for Anti-CD20 Radio-Immunotherapy (2324)
Macklis, Roger
Preliminary Results of a Prospective Study of Dose Reduced Short-Course CHOP followed by Involved Field Radiotherapyfor Elder Patients 70 Years Old or More with Localized Aggressive non-Hodgkins Lymphomas (Japan Radiation Oncology Group; JAROG Study) (2331)
Shikama, Naoto Click abstract title to view poster
Radioimmunotherapy with Yttrium 90 Ibritumomab Tiuxetan (Zevalin (2320)
Meredith, Ruby Click abstract title to view poster
Radiotherapy as Primary Treatment for Localized Stage IE and IIE Nasal NK/T Cell Lymphoma (2317)
Li, Yexiong
The Impact of Involved Field Radiation Therapy for Patients Receiving High-Dose Chemotherapy Followed by Hematopoietic Progenitor Cell Transplant for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (2328)
Wendland, Merideth
The Safety and Efficacy of Standard-Dose 90Y Ibritumomab Tiuxetan Combined with High-Dose BEAM and AutologousStem-Cell Transplantation in Patients, Including Those Over 60 Years, with Non-Hodgkin's Lymphoma (2318)
Krishnan, Amrita Click abstract title to view poster
Value of PET Restaging after Chemotherapy for Non-Hodgkins Lymphoma: Implications for Consolidation Radiotherapy (2322)
Kahn, Shannon Click abstract title to view poster






Abstracts main page


Logout